HOW TO TREAT LASIK-INDUCED NEUROTROPHIC EPITHELIOPATHY. SECOND CHANCES EXIST.
Published 2022 - 26th ESCRS Winter Meeting
Reference: P095 | Type: Abstracts | DOI: 10.82333/hheb-b528
Authors: Marta Isabel Martínez-Sánchez* 1 , Julia Cañas-Martín 1 , Rafael Cañones-Zafra 2 , Miguel A. Teus 2
1Cornea,Hospital Universitario Príncipe de Asturias,Alcalá de Henares,Spain, 2Cornea,Hospital Universitario Príncipe de Asturias,Alcalá de Henares,Spain;Refractive surgery unit,Clínica Novovisión,Madrid,Spain
Purpose
Our purpose is to present a case report of a patient who presented a LASIK-induced neurotrophic epitheliopathy (LINE) of 3 months of evolution with no response to topical treatment, whose solution was found by surgical means; Flap lift.
Setting
Refractive Surgery Unit, Clínica Novovisión, Madrid, Spain.
Methods
The following is a case of a 52-year-old woman with no history of interest who underwent FemtoLASIK surgery for hyperopia correction (planned monovision, right eye dominant). The surgery was uneventful. Soon after the procedure the patient began with dry eye symptoms and severe discomfort in her left eye and keratitis punctata superficialis was easily seen at the slit lamp. Right eye showed no relevant findings. The patient was treated with topical lubricants and cyclosporine 0.05%, with no improvement observed at 3 months postop.
Results
Conclusion
LINE is a rare LASIK complication with several mechanisms involved in its pathogenesis: cutting of the corneal nerve endings, leading to a nerve re-growth sometimes creating an abnormal sub-basal nerve plexus that shows abnormal responses to stimuli (dysesthesia). It is a rare entity with an incidence lower than 5%, and we believe that given the fact that the chances of having an abnormal corneal nerve regeneration are small, they should be even smaller if a second chance is given.